Why does the steady-state plasma concentration of a drug with high hepatic extraction ratio increase less than expected when a moderate CYP3A4 inhibitor is co-administered?

💡 Explanation

The steady-state concentration increase is blunted because hepatic drug clearance is dominated by blood flow, rather than CYP3A4 activity. Therefore, inhibiting CYP3A4 has limited impact; rather than a large increase, blood flow continues to clear the drug.

• Why does escalating drug use often lead to compulsive behavior despite diminishing euphoric effects in the reward circuitry?
• In a neuron affected by multiple sclerosis, what causes slower action potential propagation along the axon?
• In a patient with cirrhosis whose liver's ability to perform gluconeogenesis is significantly impaired, what is a likely consequence of sustained, strenuous exercise?
• If the liver's urea cycle malfunctions due to genetic enzyme deficiency, which consequence follows for the patient?
• Why does scar tissue have reduced function compared to normal skin during thermoregulation?
• A patient with severe mitral valve stenosis experiences increased left atrial pressure. Which outcome is most likely in the pulmonary circulation due to this cardiac condition?